48,837
edits
m (→Grading RCC: fix ref., adj. for format) |
|||
Line 301: | Line 301: | ||
===General=== | ===General=== | ||
Some subtypes are graded based on the '''Fuhrman system''' which considers:<ref name=Ref_GUP282>{{Ref GUP|282}}</ref> | Some subtypes are graded based on the '''Fuhrman system''' which considers:<ref name=Ref_GUP282>{{Ref GUP|282}}</ref> | ||
*Nuclear pleomorphism (size, shape) | *Nuclear pleomorphism (size, shape). | ||
*Chromatin pattern | *Chromatin pattern. | ||
*Nucleoli prominence. | *Nucleoli prominence. | ||
Notes: | Notes: | ||
*The system was validated for clear cell RCC. | *The system was validated for clear cell RCC. | ||
*Fuhrman nuclear grade is '''not''' prognostic in ''chromophobe RCC'' and should not be used in that context.<ref name= | *Fuhrman nuclear grade is '''not''' prognostic in ''chromophobe RCC'' and should not be used in that context.<ref name=pmid17527087>{{Cite journal | last1 = Delahunt | first1 = B. | last2 = Sika-Paotonu | first2 = D. | last3 = Bethwaite | first3 = PB. | last4 = McCredie | first4 = MR. | last5 = Martignoni | first5 = G. | last6 = Eble | first6 = JN. | last7 = Jordan | first7 = TW. | title = Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. | journal = Am J Surg Pathol | volume = 31 | issue = 6 | pages = 957-60 | month = Jun | year = 2007 | doi = 10.1097/01.pas.0000249446.28713.53 | PMID = 17527087 }}</ref> | ||
===Criteria & grades=== | ===Criteria & grades=== |
edits